Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

The standard therapy for patients with haemophilia is prophylactic treatment with replacement factor VIII (FVIII) or factor IX (FIX). Patients who develop inhibitors against FVIII/FIX face an increased risk of bleeding, and the likelihood of early development of progressive arthropathy, alongside hi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Haematol
Main Authors: Ljung, Rolf, Auerswald, Guenter, Benson, Gary, Dolan, Gerry, Duffy, Anne, Hermans, Cedric, Jiménez‐Yuste, Victor, Lambert, Thierry, Morfini, Massimo, Zupančić‐Šalek, Silva, Santagostino, Elena
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Review Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936224/
https://ncbi.nlm.nih.gov/pubmed/30411401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13193
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados